TruAlt Bioenergy Limited (NSE:TRUALT)
India · Delayed Price · Currency is INR 352.05
-17.75 (-4.80%)
At close: Jan 20, 2026
TruAlt Bioenergy Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 17,409 | 19,077 | 12,234 | 7,624 | - | 5,254 | |
Revenue Growth (YoY) | 42.30% | 55.94% | 60.47% | - | - | - |
Cost of Revenue | 11,204 | 12,760 | 8,080 | 5,031 | - | 3,560 |
Gross Profit | 6,204 | 6,317 | 4,154 | 2,593 | - | 1,694 |
Selling, General & Admin | 457.23 | 417.82 | 247.07 | 119.49 | - | 68.01 |
Other Operating Expenses | 2,590 | 2,803 | 2,024 | 1,423 | 0.12 | 628.45 |
Operating Expenses | 3,813 | 3,890 | 2,840 | 1,750 | 0.12 | 761.18 |
Operating Income | 2,391 | 2,427 | 1,314 | 842.96 | -0.12 | 932.64 |
Interest Expense | -1,483 | -1,406 | -1,362 | -345.69 | - | -270.62 |
Interest & Investment Income | 592.07 | 592.07 | 502.67 | - | - | 5.06 |
Currency Exchange Gain (Loss) | -0.27 | -0.27 | 0.77 | - | - | - |
Other Non Operating Income (Expenses) | 34.81 | -22.74 | -6.3 | -7.41 | - | -5.63 |
EBT Excluding Unusual Items | 1,534 | 1,590 | 448.73 | 489.85 | -0.12 | 661.45 |
Gain (Loss) on Sale of Investments | 4.26 | 4.26 | 0.01 | - | - | - |
Pretax Income | 1,539 | 1,594 | 448.74 | 489.85 | -0.12 | 661.45 |
Income Tax Expense | 2.42 | 128.04 | 130.66 | 135.25 | - | 166.48 |
Net Income | 1,536 | 1,466 | 318.08 | 354.6 | -0.12 | 494.97 |
Preferred Dividends & Other Adjustments | 5.14 | 5.14 | 58.65 | 29.33 | - | - |
Net Income to Common | 1,531 | 1,461 | 259.43 | 325.27 | -0.12 | 494.97 |
Net Income Growth | 382.95% | 361.01% | -10.30% | - | - | - |
Shares Outstanding (Basic) | 70 | 70 | 61 | 46 | 0 | 0 |
Shares Outstanding (Diluted) | 70 | 70 | 61 | 46 | 0 | 0 |
Shares Change (YoY) | 14.38% | 14.23% | 33.28% | 75023.49% | - | - |
EPS (Basic) | 21.92 | 20.94 | 4.25 | 7.10 | -2.03 | 8114.25 |
EPS (Diluted) | 21.91 | 20.94 | 4.25 | 7.10 | -2.03 | 8114.25 |
EPS Growth | 415.87% | 392.98% | -40.16% | - | - | - |
Free Cash Flow | -362.27 | 696.28 | -3,213 | -420.48 | -0 | -863.36 |
Free Cash Flow Per Share | -5.19 | 9.98 | -52.61 | -9.18 | -0.00 | -14153.39 |
Gross Margin | 35.64% | 33.11% | 33.95% | 34.01% | - | 32.24% |
Operating Margin | 13.73% | 12.72% | 10.74% | 11.06% | - | 17.75% |
Profit Margin | 8.79% | 7.66% | 2.12% | 4.27% | - | 9.42% |
Free Cash Flow Margin | -2.08% | 3.65% | -26.27% | -5.51% | - | -16.43% |
EBITDA | 3,136 | 3,084 | 1,883 | 1,050 | 64.57 | 997.34 |
EBITDA Margin | 18.01% | 16.16% | 15.39% | 13.78% | - | 18.98% |
D&A For EBITDA | 745.13 | 656.87 | 569.17 | 207.52 | 64.69 | 64.69 |
EBIT | 2,391 | 2,427 | 1,314 | 842.96 | -0.12 | 932.64 |
EBIT Margin | 13.73% | 12.72% | 10.74% | 11.06% | - | 17.75% |
Effective Tax Rate | 0.16% | 8.03% | 29.12% | 27.61% | - | 25.17% |
Revenue as Reported | 18,074 | 19,685 | 12,802 | 7,624 | - | 5,259 |
Advertising Expenses | - | 13.7 | 2.31 | 33.55 | - | 6.2 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.